Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 193 results found. Search for [ Moderna Inc ]

Results 1 to 21 of 193
June 12, 2021
In a statement on Friday, the EU drug regulator said it reviewed cases of six people with capillary leak syndrome after they had received a shot of the AstraZeneca vaccine

June 10, 2021
India has not granted indemnity to any COVID-19 vaccine maker, but the sources said the government was having a change of heart

June 9, 2021
The study will enroll up to 4,500 children at more than 90 clinical sites in the United States, Finland, Poland and Spain, the company said

June 4, 2021
There are many colleges and universities in US that are asking students to be revaccinated if they have received vaccines -- like Sputnik V and Covaxin -- that have not received WHO approval.  They are citing a lack of data on efficacy and safety of these vaccines

PB Jayakumar
June 2, 2021
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.

June 1, 2021
The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in the United States

New Delhi, May 27, 2021
Increase in input costs and supply disruptions in rural economy on account of the second COVID-19 wave are preparing the grounds for surge in inflation during this fiscal, rating agency CRISIL noted in a recent report; India's main health agency will start a study next week to examine the effectiveness of AstraZeneca's vaccine and the homegrown shot Covaxin against coronavirus, a scientist said on Wednesday; Inc said on Wednesday it is buying MGM, the fabled U.S. movie studio home to the James Bond franchise, for $8.45 billion, giving it a huge library of films and TV shows and ramping up competition with streaming rivals led by Netflix and Disney+. Watch this and more news on News Blast.

Rashi Bisaria
New Delhi, May 27, 2021
Input costs surge, rural economy woes to unleash inflation growth:CRISIL Increase in input costs and supply disruptions in rural economy on account of the second COVID-19 wave are preparing the grounds for surge in inflation during this fiscal, rating agency CRISIL noted in a recent report. While input prices have increased across the board, crude oil, edible oils, metals and minerals, and transportation costs have particularly contributed to the upward inflationary risks. ICMR plans to s...

May 25, 2021
In a high level meeting it was discussed that Moderna doesn't have surplus vaccines to share in 2021 and that it plans to launch its single-dose vaccine for the Indian market only in 2022

May 23, 2021
Efficacy against COVID-19-linked disease averaged around 85% after a full course, increasing to almost 100% protection against severe disease, hospitalisation or death, say University of Florida researchers

May 21, 2021
Moderna is the fourth COVID-19 vaccine to be approved in South Korea, following doses developed by AstraZeneca Plc , Pfizer Inc and Johnson & Johnson, said Kim

Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead

May 13, 2021
Vaccine scarcity in many low and middle-income nations has prompted researchers and public health officials to examine strategies such as mixing two different shots

May 6, 2021
Moderna had in February forecast vaccine sales of $18.4 billion. Earlier this week, larger rival Pfizer Inc said it expects $26 billion in sales of its COVID-19 vaccine this year

April 24, 2021
We are no longer recommending a pause in the use of this vaccine, CDC Director Rochelle Walensky told a news briefing

April 14, 2021
The vaccine maker said the six-month follow-up of its original late-stage study of the vaccine showed that vaccine efficacy remained consistent with its previous updates

April 10, 2021
A follow-up study of 33 people who received Moderna Inc's COVID-19 vaccine in early trials show the antibodies it induced are still present six months after the second dose

April 2, 2021
The US Food and Drug Administration (FDA) cleared Moderna to speed up vaccine output by letting it fill a single vial with up to 15 doses

March 30, 2021
The risk of infection fell 90% by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found

March 26, 2021
Nearly 66 million doses of the vaccine had been administered in the United States as of Wednesday morning, according to data from the US Centers for Disease Control and Prevention

PAGES 1 OF 10  12345